RUNNING HEAD: Anomalous Experiences and Hypnotic Suggestibility
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
An FAQ Explaining the Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly
Pharmacy Quality Measures An FAQ Explaining the Use of Benzodiazepine Sedative Hypnotic Medications in the Elderly by Natalie Bari WHERE DOES THIS MEASURE sures feature medications from the the diagnoses (such as insomnia, agi- FIT INTO THE OVERALL MEDI- American Geriatrics Society’s Beers tation, delirium) that the Beers Criteria CARE PART D STAR RATINGS? Criteria for potentially inappropriate state should be avoided. This measure was endorsed by the medication use in older adults. The Pharmacy Quality Alliance (PQA) original HRM measure discussed the WHAT DOES THIS MEASURE in May 2014. But to date, it has not use of non-benzodiazepine sedative ANALYZE? been adopted by the Medicare Part D hypnotics, but it did not include This measure calculates the percent of Star Ratings program. The measure benzodiazepines as they were listed as patients 65 years of age and older who is often described as an extension “avoid only for treatment of insomnia, have received two or more prescription of the PQA measure on the use of agitation or delirium.” The additional fills for any benzodiazepine sedative high-risk medications in the elderly measure was created to address the hypnotic for a cumulative period of (HRM), which was used in the calcu- concern that an unintended conse- more than 90 days. The benzodiaze- lation of the CMS 2015 Star Ratings quence of the HRM measure would be pine sedative hypnotic medications using 2013 claims data. Both mea- increased use of benzodiazepines for are defined to include estazolam, 32 America’s PHARMACIST | January 2015 temazepam, triazolam, flurazepam, them frequently over a prolonged peri- use of the benzodiazepine agents spe- and quazepam. -
Herbal Remedies and Their Possible Effect on the Gabaergic System and Sleep
nutrients Review Herbal Remedies and Their Possible Effect on the GABAergic System and Sleep Oliviero Bruni 1,* , Luigi Ferini-Strambi 2,3, Elena Giacomoni 4 and Paolo Pellegrino 4 1 Department of Developmental and Social Psychology, Sapienza University, 00185 Rome, Italy 2 Department of Neurology, Ospedale San Raffaele Turro, 20127 Milan, Italy; [email protected] 3 Sleep Disorders Center, Vita-Salute San Raffaele University, 20132 Milan, Italy 4 Department of Medical Affairs, Sanofi Consumer HealthCare, 20158 Milan, Italy; Elena.Giacomoni@sanofi.com (E.G.); Paolo.Pellegrino@sanofi.com (P.P.) * Correspondence: [email protected]; Tel.: +39-33-5607-8964; Fax: +39-06-3377-5941 Abstract: Sleep is an essential component of physical and emotional well-being, and lack, or dis- ruption, of sleep due to insomnia is a highly prevalent problem. The interest in complementary and alternative medicines for treating or preventing insomnia has increased recently. Centuries-old herbal treatments, popular for their safety and effectiveness, include valerian, passionflower, lemon balm, lavender, and Californian poppy. These herbal medicines have been shown to reduce sleep latency and increase subjective and objective measures of sleep quality. Research into their molecular components revealed that their sedative and sleep-promoting properties rely on interactions with various neurotransmitter systems in the brain. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter that plays a major role in controlling different vigilance states. GABA receptors are the targets of many pharmacological treatments for insomnia, such as benzodiazepines. Here, we perform a systematic analysis of studies assessing the mechanisms of action of various herbal medicines on different subtypes of GABA receptors in the context of sleep control. -
Drug Class Review on Newer Sedative Hypnotics
Drug Class Review on Newer Sedative Hypnotics Final Report December 2005 The Agency for Healthcare Research and Quality has not yet seen or approved this report The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports. Susan Carson, MPH Po-Yin Yen, MS Marian S. McDonagh, PharmD Oregon Evidence-based Practice Center Oregon Health & Science University Mark Helfand, MD, MPH, Director Copyright © 2005 by Oregon Health & Science University Portland, Oregon 97201. All rights reserved. Final Report Drug Effectiveness Review Project TABLE OF CONTENTS Introduction....................................................................................................................... 4 Scope and Key Questions ............................................................................................. 4 Methods.............................................................................................................................. 6 Literature Search........................................................................................................... 6 Study Selection ............................................................................................................ -
Anomalous Experiences and Hypnosis
Anomalous experiences and hypnosis Anomalous experiences and hypnosis Etzel Cardeña, Ph.D. Thorsen Professor of Psychology, Lund University, Sweden Running head: Anomalous experiences and hypnosis Corresponding author: Etzel Cardeña, Ph. D. Thorsen Professor Department of Psychology Lund University P.O. Box 213 SE-221 00 Lund, Sweden Telephone number: (0)46 46 2228770, fax (department of psychology) 46 46 222 4209 email: [email protected] webpage: http://www.psychology.lu.se/Personal/e_cardena/ Anomalous experiences and hypnosis Abstract Throughout its history, mesmerism and its later development as hypnosis have been related to reputed psi-phenomena and to various alterations of consciousness. Although most of the older literature would not stand up to current methodological strictures, there are some reports that are still baffling and both the consistency of the reports and more recent meta- analytic work suggest that we should investigate the psi-hypnosis relationship more programmatically. With respect to alterations of consciousness within the hypnotic context, most previous work has had the confound of specific suggestions. In this paper I review the literature on hypnotic phenomenology, point out its limitations, and present recently published data that supports specific alterations associated with experienced depth: mostly relaxation during a resting baseline, mild to moderate changes in sensations and body image during light/medium hypnosis, and radical alterations of body image (e.g., floating, sinking), and dreamlike and transcendental (e. g,, merging with a light) during deep and very deep hypnosis. Many of these phenomena have also been observed during other altered states such as OBEs and NDEs, which have been of great interest to the parapsychology field. -
Public Law 106-172 106Th Congress An
PUBLIC LAW 106-172—FEB. 18, 2000 114 STAT. 7 Public Law 106-172 106th Congress An Act To amend the Controlled Substances Act to direct the^ emergency scheduling of gamma hydroxybutyric acid, to provide for a national awareness campaign, and Feb. 18, 2000 for other piu"poses. [H.R. 2130] Be it enacted by the Senate and House of Representatives of the United States of America in Congress assewMed, Hillory J. Farias and Samantha SECTION 1. SHORT TITLE. Reid Date-Rape Drug Prohibition This Act may be cited as the "Hillory J. IFarias and Samantha Act of 2000. Reid Date-Rape Drug Prohibition Act of 2000". Law enforcement and crimes. SEC. 2. FINDINGS. 21 use 801 note. Congress finds as follows: 21 use 812 note. (1) Gamma hydroxybutyric acid (also called G, Liquid X, Liquid Ecstasy, Grievous Bodily Harm, Georgia Home Boy, Scoop) has become a significant and growing problem in law enforcement. At least 20 States have sclieduled such drug in their drug laws and law enforcement officials have been experi encing an increased presence of the dinig in driving under the influence, sexual assault, and overdose cases especially at night clubs and parties. (2) A behavioral depressant and a hypnotic, gamma hydroxybutyric acid ("GHB") is being used in conjunction with alcohol and other drugs with detrimental effects in an increasing number of cases. It is difficult to isolate the impact of such drug's ingestion since it is so typically taken with an ever-changing array of other drugs £md especially alcohol which potentiates its impact. (3) GHB takes the same path as alcohol, processes via alcohol dehydrogenase, and its symptoms at high levels of intake and as impact builds are comparable to alcohol inges- i- tion/intoxication. -
Anomalous/Paranormal Experiences Reported by Nurses Themselves
Anomalous/Paranormal Experiences Reported by Nurses Themselves and in Relation With Theirs Patients in Hospitals: Examining Psychological, Personality and Phenomenological Variables (Grant 246/14) ALEJANDRO PARRA & IRMA CAPUTO Instituto de Psicología Paranormal, Buenos Aires, Argentina [email protected] Abstract. The aim of this study was to determine the degree of occurrence of certain unusual perceptual experiences in hospital settings, so called Anomalous/Paranormal Experiences (APE), often related by nurses and carers. Two studies were carried out: The first one on one single hospital measuring three psychological variables, such as work stress, hallucination proneness and absorption; and the second one on multiple hospitals (N= 39) using two additional variables, such as schizotypy proneness and empathy. For study 1, one hundred nurses were grouped as 54 experiencers and 46 “control” (nonexperiencers). The most common anomalous experiences reported by nurses are sense of presence and/or apparitions, hearing noises, voices or dialogues, and intuitions and ESP experiences as listerners of experiences of their patients, such as near death experiences, religious interventions, and out-of-body experiences. Nurses reporting such experiences did not tended to score higher work stress, which not confirmed H1. However, nurses reporting experiences tended to report greater absorption and proneness to hallucinate confirming hypothesis H2 and H3 respectively, compared with those who did not report such experiences. For study 2, three hundred forty four nurses were recruited from 36 hospitals and health centers in Buenos Aires. They were grouped 235 experiencers and 109 nonexperiencers. The most common experiences are sense of presence and/or apparitions, hearing noises, voices or dialogues, crying or complaining, intuitions and ESP experiences and as listerners of experiences of their patients, such as near death experiences, religious interventions, and many anomalous experiences in relation with children. -
Anomalous Experiences, Trauma, and Symbolization Processes at the Frontiers Between Psychoanalysis and Cognitive Neurosciences
ORIGINAL RESEARCH published: 21 December 2015 doi: 10.3389/fpsyg.2015.01926 Anomalous Experiences, Trauma, and Symbolization Processes at the Frontiers between Psychoanalysis and Cognitive Neurosciences Thomas Rabeyron 1, 2* and Tianna Loose 2, 3 1 Department of Psychology, University of Nantes, Nantes, France, 2 Department of Psychology, University of Edinburgh, Edinburgh, UK, 3 Department of Psychology, University of Québec in Montreal, Montreal, QC, Canada Anomalous or exceptional experiences are uncommon experiences which are usually interpreted as being paranormal by those who report them. These experiences have long remained difficult to explain, but current progress in cognitive neuroscience and psychoanalysis sheds light on the contexts in which they emerge, as well as on their underlying processes. Following a brief description of the different types of anomalous experiences, we underline how they can be better understood at the frontiers between psychoanalysis and cognitive neurosciences. In this regard, three main lines of research Edited by: Stijn Vanheule, are discussed and illustrated, alongside clinical cases which come from a clinical service Ghent University, Belgium specializing in anomalous experiences. First, we study the links between anomalous Reviewed by: experiences and hallucinatory processes, by showing that anomalous experiences Jonathan Douglas Redmond, frequently occur as a specific reaction to negative life events, in which case they mainly Deakin University, Australia Diana Caine, take the form of non-pathological hallucinations. Next, we propose to analyze these National Hospital for Neurology and experiences from the perspective of their traumatic aspects and the altered states Neurosurgery, UK of consciousness they often imply. Finally, these experiences are considered to be *Correspondence: Thomas Rabeyron the consequence of a hypersensitivity that can be linked to an increase in psychic [email protected] permeability. -
Spontaneous Paper – Notes
Wilde, D. and Murray, C.D. (in press) The evolving self: finding meaning in near-death experiences using interpretative phenomenological analysis. Mental Health, Religion and Culture. Abstract Objectives: A variety of anomalous experiences have been reported in the research literature as enhancing, rather than indicating poor mental health. The out-of-body experience (OBE), where the person‟s self and body are phenomenologically separate, is a relatively common anomalous experience. The aim of this study was to investigate the experience of an OBE and its resultant after-effects. Design: An idiographic, phenomenological, qualitative approach was adopted. Methods: Three participants took part in recorded face-to-face, semi-structured interviews. Data were analysed using Interpretative Phenomenological Analysis. Results: IPA found experients perceived their OBEs as occurring at times of personal significance. They were inextricably linked with participants‟ lives beyond their point of occurrence and played an adaptive role in response to difficult life events. The process of integration was helped or hindered by the varying reactions from others to the disclosure of the OBE. Conclusions: The idiographic nature of this study was instrumental in highlighting the subtle personal and social factors that influenced how the OBE was managed and integrated. Key words: Anomalous experiences; out-of-body experiences; Interpretative phenomenological analysis; mental health; qualitative methodology 1 Introduction The Out-of-Body Experience (OBE), whereby “the centre of consciousness appears to the experient to occupy temporarily a position which is spatially remote from his/her body” (Irwin, 1985, p.5) has been a topic of research in the psychological sciences for over 100 years (Alvarado, 1992). -
Insomnia in Adults
New Guideline February 2017 The AASM has published a new clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults. These new recommendations are based on a systematic review of the literature on individual drugs commonly used to treat insomnia, and were developed using the GRADE methodology. The recommendations in this guideline define principles of practice that should meet the needs of most adult patients, when pharmacologic treatment of chronic insomnia is indicated. The clinical practice guideline is an essential update to the clinical guideline document: Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307–349. SPECIAL ARTICLE Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults Sharon Schutte-Rodin, M.D.1; Lauren Broch, Ph.D.2; Daniel Buysse, M.D.3; Cynthia Dorsey, Ph.D.4; Michael Sateia, M.D.5 1Penn Sleep Centers, Philadelphia, PA; 2Good Samaritan Hospital, Suffern, NY; 3UPMC Sleep Medicine Center, Pittsburgh, PA; 4SleepHealth Centers, Bedford, MA; 5Dartmouth-Hitchcock Medical Center, Lebanon, NH Insomnia is the most prevalent sleep disorder in the general popula- and disease management of chronic adult insomnia, using existing tion, and is commonly encountered in medical practices. Insomnia is evidence-based insomnia practice parameters where available, and defined as the subjective perception of difficulty with sleep initiation, consensus-based recommendations to bridge areas where such pa- duration, consolidation, or quality that occurs despite adequate oppor- rameters do not exist. -
The Neurocognitive Factors Underlying Anomalous Experience in the Non-Clinical Population
THE NEUROCOGNITIVE FACTORS UNDERLYING ANOMALOUS EXPERIENCE IN THE NON-CLINICAL POPULATION by RACHEL ELLEN MARCHANT A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY School of Psychology College of Life and Environmental Sciences University of Birmingham September 2019 Corrections submitted December 2020 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence. You are free to: Share — copy and redistribute the material in any medium or format The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. Notices: You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation. No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material. -
Self-Mutilating Behavior in Patients with Dissociative Disorders: the Role of Innate Hypnotic Capacity
Isr J Psychiatry Relat Sci Vol 45 No. 1 (2008) 39–48 Self-Mutilating Behavior in Patients with Dissociative Disorders: The Role of Innate Hypnotic Capacity Servet Ebrinc, MD,1 Umit B. Semiz, MD,1 Cengiz Basoglu, MD,1 Mesut Cetin, MD,1 Mehmet Y. Agargun, MD,2 Ayhan Algul, MD,1 and Alpay Ates, MD1 1 GATA Haydarpasa Training Hospital, Department of Psychiatry, Istanbul, Turkey ý 2 Yuzuncu Y l University, School of Medicine, Department of Psychiatry, Van, Turkey. Abstract: Background: Despite the fact that the assumption of a relationship between self-mutilation and dissociative disorders (DD) has a long history, there is little empirical evidence to support this premise. The present study exam- ined this relationship and investigated whether this commonality is associated with innate hypnotic capacity. Methods: Fifty patients diagnosed with DD and 50 control subjects with major depression were assessed by using a self-mutila- tion questionnaire, Dissociative Experiences Scale, Traumatic Experiences Checklist, and the Eye-Roll Sign for their self-mutilating behaviors, dissociative symptoms, early trauma, and innate hypnotic capacity, respectively. Results: We have found that 82% of the present sample of patients with DD injured themselves. They had higher scores on trauma, dissociation and eye-roll measurements than controls. In addition, DD patients with self-mutilation were more likely to have high scores of trauma, dissociation and eye-roll than those without self-mutilation. Innate hypnotic capacity was a strong predictor of self-mutilating behavior in DD patients. Conclusions: This study strongly supports the as- sumption that patients with DD are at high risk for self-mutilating behavior and points to the necessity of routine screening for self-mutilating behavior as well as the hypnotic capacity which may constitute a high risk for self-injury in this patient group. -
Valerian SUSAN HADLEY, M.D., Middlesex Hospital, Middletown, Connecticut JUDITH J
COMPLEMENTARY AND ALTERNATIVE MEDICINE Valerian SUSAN HADLEY, M.D., Middlesex Hospital, Middletown, Connecticut JUDITH J. PETRY, M.D., Vermont Healing Tools Project, Brattleboro, Vermont Valerian is a traditional herbal sleep remedy that has been studied with a variety of methodologic designs using multiple dosages and preparations. Research has focused on subjective evaluations of sleep patterns, particularly sleep latency, and study populations have primarily consisted of self-described poor sleepers. Valerian improves subjective experiences of sleep when taken nightly over one- to two-week periods, and it appears to be a safe sedative/hypnotic choice in patients with mild to moderate insomnia. The evi- dence for single-dose effect is contradictory. Valerian is also used in patients with mild anxiety, but the data supporting this indication are limited. Although the adverse effect profile and tolerability of this herb are excellent, long-term safety studies are lacking. (Am Fam Physician 2003;67:1755-8. Copyright©2003 American Academy of Family Physicians) he root of valerian, a perennial triates, valeric acid) and interaction with neu- herb native to North America, rotransmitters such as GABA (valeric acid and Asia, and Europe, is used most unknown fractions).2,3 commonly for its sedative and hypnotic properties in patients Uses and Efficacy Twith insomnia, and less commonly as an SEDATIVE/HYPNOTIC anxiolytic. Multiple preparations are available, Several clinical studies have shown that and the herb is commonly combined with valerian is effective in the treatment of insom- other herbal medications. This review nia, most often by reducing sleep latency. A addresses only studies that used valerian root double-blind, placebo-controlled trial4 com- as an isolated herb.